Therapy Areas: Infectious Diseases
Innoviva Specialty Therapeutics signs licensing agreement with Dr. Reddy's for XACDURO international expansion
16 June 2026 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc (Nasdaq:INVA) focused on innovative therapies in critical care and infectious disease, said on Tuesday that it has entered ...
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
12 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that it is donating more than 2,000 vials of remdesivir to the Republic of Uganda to support response eff...
RedHill Biopharma advancing opaganib options for Ebola outbreak
4 June 2026 - Specialty biopharmaceutical company RedHill Biopharma Ltd (Nasdaq:RDHL) announced on Wednesday that it is actively discussing potential collaborations for advancement of its investigatio...
Transgene to present preclinical TG-MVA mpox vaccine data at World Congress on Infectious Diseases
26 May 2026 - French biotech company Transgene (Euronext Paris:TNG) announced on Tuesday that it will present new preclinical data on its TG-MVA prophylactic vaccine candidates against mpox at the Wor...
Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment
21 May 2026 - South Korea-based biotechnology company Hyundai Bioscience announced on Wednesday that XAFTY has a strong likelihood of being able to treat Ebola and Hantavirus due to its low IC50 (50% ...
Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses
24 April 2026 - Canadian pharmaceutical company Apotex Inc and Cumberland Pharmaceuticals Inc, a US-based specialty pharmaceutical company, announced on Thursday that they have entered into a strategi...